[Evidence-based therapy of polycystic ovarian syndrome]
- PMID: 26551444
- DOI: 10.1556/650.2015.30253
[Evidence-based therapy of polycystic ovarian syndrome]
Abstract
Polycystic ovary syndrome is recognized as the most common hormonal and metabolic disorder likely to affect women. The heterogeneous endocrinopathy is characterized by clinical and/or biochemical hyperandrogenism, oligo- or amenorrhoea, anovulatory infertility, and polycystic ovarian morphology. The syndrome is often associated with obesity, hyperinsulinemia and adversely affects endocrine, metabolic, and cardiovascular health. The symptoms and complaint of the patients vary with age. To maximise health gain of the syndrome, adequate, evidence based effective, efficient and safe treatment is necessary. This article summarises the highest available evidence provided by studies, meta-analysis and systematic reviews about the therapeutical possibilities for treating obesity, hyperandrogenism, menstrual abnormalities, infertility and psychological problems related to polycystic ovary syndrome.
Keywords: EBM; PCOS; clinical features; klinikai tünetek; terápia; therapy.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical